These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35308690)

  • 1. Radiation Induced Abscopal Effect in a Patient With Malignant Pleural Mesothelioma on Pembrolizumab.
    Rittberg R; Chan E; Yip S; Alex D; Ho C
    Cureus; 2022 Feb; 14(2):e22159. PubMed ID: 35308690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abscopal effect in a patient with malignant pleural mesothelioma treated with palliative radiotherapy and pembrolizumab.
    Mampuya WA; Bouchaab H; Schaefer N; Kinj R; La Rosa S; Letovanec I; Ozsahin M; Bourhis J; Coukos G; Peters S; Herrera FG
    Clin Transl Radiat Oncol; 2021 Mar; 27():85-88. PubMed ID: 33532635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-ever Abscopal Effect after Palliative Radiotherapy and Immuno-gene Therapy for Malignant Pleural Mesothelioma.
    Barsky AR; Cengel KA; Katz SI; Sterman DH; Simone CB
    Cureus; 2019 Feb; 11(2):e4102. PubMed ID: 31057996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition.
    Trommer M; Yeo SY; Persigehl T; Bunck A; Grüll H; Schlaak M; Theurich S; von Bergwelt-Baildon M; Morgenthaler J; Herter JM; Celik E; Marnitz S; Baues C
    Front Pharmacol; 2019; 10():511. PubMed ID: 31156434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials.
    Theelen WSME; Chen D; Verma V; Hobbs BP; Peulen HMU; Aerts JGJV; Bahce I; Niemeijer ALN; Chang JY; de Groot PM; Nguyen QN; Comeaux NI; Simon GR; Skoulidis F; Lin SH; He K; Patel R; Heymach J; Baas P; Welsh JW
    Lancet Respir Med; 2021 May; 9(5):467-475. PubMed ID: 33096027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abscopal Effect of Radiotherapy Enhanced with Immune Checkpoint Inhibitors of Triple Negative Breast Cancer in 4T1 Mammary Carcinoma Model.
    Song HN; Jin H; Kim JH; Ha IB; Kang KM; Choi HS; Jeong HJ; Kim MY; Kim HJ; Jeong BK
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abscopal effect and resistance reversion in nivolumab-treated non-small-cell lung cancer undergoing palliative radiotherapy: a case report.
    Fiorica F; Belluomini L; Giuliani J; Urbini B; Milella M; Frassoldati A; Pilotto S; Giorgi C
    Immunotherapy; 2021 Aug; 13(12):971-976. PubMed ID: 34180714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia.
    Chi MS; Mehta MP; Yang KL; Lai HC; Lin YC; Ko HL; Wang YS; Liao KW; Chi KH
    Front Oncol; 2020; 10():254. PubMed ID: 32211319
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of the Abscopal Effect With Anti-PD1 Therapy in Patients With Metastatic Solid Tumors.
    Ribeiro Gomes J; Schmerling RA; Haddad CK; Racy DJ; Ferrigno R; Gil E; Zanuncio P; Buzaid AC
    J Immunother; 2016; 39(9):367-372. PubMed ID: 27741091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volumetric PET Response Assessment Outperforms Conventional Criteria in Patients Receiving High-Dose Pembrolizumab for Malignant Mesothelioma.
    Ferdinandus J; Barbato F; Chodyla M; Fendler WP; Kessler L; Pomykala KL; Metzenmacher M; Krefting F; Hager T; Umutlu L; Herrmann K; Christoph DC
    J Nucl Med; 2021 Feb; 62(2):191-194. PubMed ID: 32532926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration.
    Yamaguchi T; Fushida S; Kinoshita J; Saito H; Shimada M; Terai S; Moriyama H; Okamoto K; Nakamura K; Ninomiya I; Inaki N
    Surg Case Rep; 2021 Dec; 7(1):253. PubMed ID: 34882298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abscopal effect of radiotherapy combined with immune checkpoint inhibitors.
    Liu Y; Dong Y; Kong L; Shi F; Zhu H; Yu J
    J Hematol Oncol; 2018 Aug; 11(1):104. PubMed ID: 30115069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abscopal effect of radiation on lymph node metastasis in esophageal carcinoma: A case report and literature review.
    Zhao X; Kang J; Zhao R
    Oncol Lett; 2018 Sep; 16(3):3555-3560. PubMed ID: 30127961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Radiotherapy on the Efficacy and Toxicity of anti-PD-1 Inhibitors in Metastatic NSCLC.
    Samuel E; Lie G; Balasubramanian A; Hiong A; So Y; Voskoboynik M; Moore M; Shackleton M; Haydon A; John T; Mitchell PLR; Markman B; Briggs P; Parakh S
    Clin Lung Cancer; 2021 May; 22(3):e425-e430. PubMed ID: 32778511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial.
    Popat S; Curioni-Fontecedro A; Dafni U; Shah R; O'Brien M; Pope A; Fisher P; Spicer J; Roy A; Gilligan D; Gautschi O; Nadal E; Janthur WD; López Castro R; García Campelo R; Rusakiewicz S; Letovanec I; Polydoropoulou V; Roschitzki-Voser H; Ruepp B; Gasca-Ruchti A; Peters S; Stahel RA
    Ann Oncol; 2020 Dec; 31(12):1734-1745. PubMed ID: 32976938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Complete Response to Pembrolizumab in Malignant Peritoneal Mesothelioma: A Case Report.
    Bairos Menezes M; Pedroso de Lima R; Dunões I; Inácio M; Dinis R
    Cureus; 2024 Jan; 16(1):e52716. PubMed ID: 38384604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy-induced abscopal effect twice after pembrolizumab failure in hereditary leiomyomatosis and renal cell carcinoma: a case report with genetic and immunologic analysis.
    Zhang X; Zhang Y; Liu Y; Yang Y; Dong P; He L; Zhou F
    Transl Androl Urol; 2021 Nov; 10(11):4304-4312. PubMed ID: 34984195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial.
    Alley EW; Lopez J; Santoro A; Morosky A; Saraf S; Piperdi B; van Brummelen E
    Lancet Oncol; 2017 May; 18(5):623-630. PubMed ID: 28291584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. True abscopal effect in a patient with metastatic non-small cell lung cancer.
    Vilinovszki O; Andratschke N; Huellner M; Curioni-Fontecedro A; Kroeze SGC
    Radiat Oncol; 2021 Oct; 16(1):194. PubMed ID: 34600561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.
    Grimaldi AM; Simeone E; Giannarelli D; Muto P; Falivene S; Borzillo V; Giugliano FM; Sandomenico F; Petrillo A; Curvietto M; Esposito A; Paone M; Palla M; Palmieri G; Caracò C; Ciliberto G; Mozzillo N; Ascierto PA
    Oncoimmunology; 2014; 3():e28780. PubMed ID: 25083318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.